Global Anti-Infective Vaccines Industry Insights: Market Size, Growth Analysis and Forecast

Report ID : 1290868 | Published : August 2025 | Study Period : 2023-2033 | Format : PDF + Excel

The market size of the Anti-Infective Vaccines Industry is categorized based on Vaccine Type (Live Attenuated Vaccines, Inactivated Vaccines, Subunit Vaccines, Toxoid Vaccines, Conjugate Vaccines) and Indication (Bacterial Infections, Viral Infections, Fungal Infections, Parasitic Infections, Others) and Distribution Channel (Pharmacies, Hospitals, Online Sales, Public Health Organizations, Others) and geographical regions (North America, Europe, Asia-Pacific, South America, and Middle-East and Africa).

The Anti-Infective Vaccines Industry was worth 45 billion USD in 2023 and is forecasted to reach 75 billion USD by 2033, growing at a CAGR of 5.3% over the period 2024-2033. This report covers various segments and analyzes the key trends and factors influencing the market significantly.

The anti infectious disease vaccines market encompasses the development, production and distribution of vaccines aimed at preventing diseases due to infections globally thus it is very important in the health care systems around the world. With new pathogens emerging and antibiotic treatment options becoming fewer and fewer vaccination and preventive tacktics have never been more important. Besides being a response to the need of improving the general health of populations, this market is also an evolving and active sector in the biopharmaceutical space as new ideas and partnerships continue to define its future.

Additionally, with the increasing focus of the organizations globally on treating rather then waiting for the ailments the supply of anti infectious vaccines is on the rise. Countries, healthcare systems and pharmaceutical companies are funding development projects geared towards improving the effectiveness and availability more than ever before. This growth in spending overturns the need to safeguard people from bacteria, viruses, and parasite based diseases. The market is developing at a rapid pace and is creating challenges and opportunities for market players.

As per this scenario, Verified Industry Insights envisages offering detailed industry reports, which will assess the dynamics of the anti infective vaccines market and spot the challenges and opportunities. By gathering evidence and insights from different sources, we assist our clients to make fruitful choices while managing the intricacies of this critical sector. In the context of our understanding of the necessary anti – infective vaccines, we strive to provide our clients with reliable, easy to understand and implement information making us their preferred partner.

 

ATTRIBUTES	DETAILS
STUDY PERIOD	2023-2033
BASE YEAR	2023
FORECAST PERIOD	2024-2033
HISTORICAL PERIOD	2023-2024
UNIT	VALUE (USD BILLION)
KEY COMPANIES PROFILED	Pfizer Inc., Merck & Co. Inc., GlaxoSmithKline plc, Sanofi S.A., Johnson & Johnson, AstraZeneca PLC, Novartis AG, Bayer AG, Bristol-Myers Squibb Company, AbbVie Inc., Moderna Inc.
SEGMENTS COVERED	By Vaccine Type - Live Attenuated Vaccines, Inactivated Vaccines, Subunit Vaccines, Toxoid Vaccines, Conjugate Vaccines By Indication - Bacterial Infections, Viral Infections, Fungal Infections, Parasitic Infections, Others By Distribution Channel - Pharmacies, Hospitals, Online Sales, Public Health Organizations, Others By Geography - North America, Europe, APAC, Middle East Asia & Rest of World.

---

Anti-Infective Vaccines Industry Dynamics

The Anti-Infective Vaccines Industry is undergoing significant changes due to various dynamic factors. This section delves into the key drivers, restraints, opportunities, and challenges that are shaping the market landscape.

Market Drivers

1. Technological Advancements
2. Increasing Consumer Demand
3. Regulatory Support
4. Globalization

Market Restraints

1. High Operational Costs
2. Regulatory Challenges
3. Market Saturation

Market Opportunities

1. Emerging Markets
2. Product Innovation
3. Strategic Partnerships

Market Challenges

1. Technological Disruptions
2. Supply Chain Issues
3. Changing Consumer Preferences

---

Key Players in the Anti-Infective Vaccines Industry

This report provides an in-depth analysis of both established and rising industry participants. It provides broad lists of important companies organized by the types of products they offer and other market-related factors. In addition to characterizing these companies, the report contains the year each player entered the market, which is useful for research analysis by the study's analysts.

• Pfizer Inc.
• Merck & Co. Inc.
• GlaxoSmithKline plc
• Sanofi S.A.
• Johnson & Johnson
• AstraZeneca PLC
• Novartis AG
• Bayer AG
• Bristol-Myers Squibb Company
• AbbVie Inc.
• Moderna Inc.

---

Customization Options

Verified Industry Insights offers one of the following report customization options to our respectable clients :

Company Profiling

● Detailed profiling of additional market players (up to three players)
● SWOT analysis of key players (up to three players)

Competitive Benchmarking

● Benchmarking of key players on the following parameters : Product portfolio, geographical reach, regional presence, and strategic alliances.

Custom Research

Verified Industry Insights offers custom research services across sectors. In case of any custom research requirement related to market assessment, competitive benchmarking, sourcing and procurement, target screening, and others, please send your inquiry to [email protected] or call us at +1 743 222 5439

© 2024 Verified Industry Insights. All Rights Reserved